Background The atherogenic milieu of hypertension,hyperglycaemia and dyslipidaemia results in anexcess of cardiovascular deaths in the diabetic population. Objective To determine the efficacy and long-term success of a pharmacist-delivered cardiovascular risk reduction clinic. Methods Patients with diabetes not achieving blood pressure (BP) and lipid targets at a standard diabetes clinic had a mean of four visits to the pharmacist-delivered clinic. Results BP was significantly reduced by attending the clinic (mean reduction in clinic BP 23/10 mmHg). Ambulatory BP monitoring demonstrated a mean reduction of 13/9 mmHg from clinic entry to discharge and this effect was sustained six months post-discharge. Total cholesterol was reduced by 0.4 m...
Purpose To assess whether VA MEDIC-E (Veterans Affairs Multi-disciplinary Education and Diabetes Int...
OBJECTIVE — There are national mandates to reduce blood pressure (BP) to 130/85 mmHg, LDL cholestero...
Background: There is insufficient evidence for the efficacy of comprehensive multiple risk factor in...
Background The atherogenic milieu of hypertension,hyperglycaemia and dyslipidaemia results in anexce...
The authors evaluated maintenance of achieved cardiovascular risk control after discharge from a pha...
Background and objective A Pharmacist-led Diabetes Cardiovascular Risk (DCVR) reduction clinic is es...
Coexisting mental health conditions (MHCs) attenuate treatment effects in diabetes. A retrospective ...
Aims: To document in recent cohorts the degree of control of major cardiovascular (CV) risk factors ...
OBJECTIVEdThis systematic review and meta-analysis of randomized controlled trials (RCTs) assesses t...
Patients with resistant hypertension attend the DCVR clinic which has been shown to achieve sustaine...
The Cardiovascular Risk Reduction Clinic (CRRC) is a pharmacist-coordinated care model that incorpor...
Glen J Pearson1,5, Kari L Olson6, Nicole E Panich1, Sumit R Majumdar2,5, Ross T Tsuyuki1,4, Dawna M ...
Pharmaceutical care (PC) is a process through whicha pharmacist works with other healthcareprofessio...
Objective: To examine the effect of a 12-month pharmaceutical care (PC) program on vascular risk in ...
Cardiovascular disease is a leading cause of death and hospitalizations in Canada. Most risk factor...
Purpose To assess whether VA MEDIC-E (Veterans Affairs Multi-disciplinary Education and Diabetes Int...
OBJECTIVE — There are national mandates to reduce blood pressure (BP) to 130/85 mmHg, LDL cholestero...
Background: There is insufficient evidence for the efficacy of comprehensive multiple risk factor in...
Background The atherogenic milieu of hypertension,hyperglycaemia and dyslipidaemia results in anexce...
The authors evaluated maintenance of achieved cardiovascular risk control after discharge from a pha...
Background and objective A Pharmacist-led Diabetes Cardiovascular Risk (DCVR) reduction clinic is es...
Coexisting mental health conditions (MHCs) attenuate treatment effects in diabetes. A retrospective ...
Aims: To document in recent cohorts the degree of control of major cardiovascular (CV) risk factors ...
OBJECTIVEdThis systematic review and meta-analysis of randomized controlled trials (RCTs) assesses t...
Patients with resistant hypertension attend the DCVR clinic which has been shown to achieve sustaine...
The Cardiovascular Risk Reduction Clinic (CRRC) is a pharmacist-coordinated care model that incorpor...
Glen J Pearson1,5, Kari L Olson6, Nicole E Panich1, Sumit R Majumdar2,5, Ross T Tsuyuki1,4, Dawna M ...
Pharmaceutical care (PC) is a process through whicha pharmacist works with other healthcareprofessio...
Objective: To examine the effect of a 12-month pharmaceutical care (PC) program on vascular risk in ...
Cardiovascular disease is a leading cause of death and hospitalizations in Canada. Most risk factor...
Purpose To assess whether VA MEDIC-E (Veterans Affairs Multi-disciplinary Education and Diabetes Int...
OBJECTIVE — There are national mandates to reduce blood pressure (BP) to 130/85 mmHg, LDL cholestero...
Background: There is insufficient evidence for the efficacy of comprehensive multiple risk factor in...